Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Classificação em ações #340
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Preço da ação
$49.11
Valor de mercado
$73.00B
Variação (1 dia)
2.22%
Variação (1 ano)
-53.96%
País
US
Negociar Boston Scientific Corporation (BSX)

Categoria

Receita da Boston Scientific Corporation (BSX)
Receita em Jun 2026 TTM: $21.00B
De acordo com os últimos relatórios financeiros da Boston Scientific Corporation, a receita atual da empresa (TTM) é $21.00B. Em 2024, a empresa obteve uma receita de $16.75B um aumento em relação a a receita do ano 2023, que foi de $14.24B. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Boston Scientific Corporation de 2000 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $21.00B 4.59%
2025 $20.07B 19.87%
2024 $16.75B 17.61%
2023 $14.24B 12.29%
2022 $12.68B 6.68%
2021 $11.89B 19.92%
2020 $9.91B -7.66%
2019 $10.74B 9.28%
2018 $9.82B 8.57%
2017 $9.05B 7.89%
2016 $8.39B 12.16%
2015 $7.48B 1.31%
2014 $7.38B 3.32%
2013 $7.14B -1.46%
2012 $7.25B -4.89%
2011 $7.62B -2.36%
2010 $7.81B -4.67%
2009 $8.19B 1.71%
2008 $8.05B -3.67%
2007 $8.36B 6.85%
2006 $7.82B 24.48%
2005 $6.28B 11.72%
2004 $5.62B 61.80%
2003 $3.48B 19.08%
2002 $2.92B 9.20%
2001 $2.67B 0.34%
2000 $2.66B 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
$46.59B 121.88%
US
$25.84B 23.06%
US
$35.48B 69.00%
IE
$6.51B -68.98%
US
- -
DE